- Report
- October 2023
- 161 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- July 2023
- 173 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- June 2023
- 159 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- October 2022
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- April 2022
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- January 2022
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- July 2021
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
From €2484EUR$2,500USD£2,065GBP
- Report
- October 2020
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- January 2024
- 55 Pages
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- September 2022
- 252 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- February 2021
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- November 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- November 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- May 2023
- 147 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- November 2023
- 160 Pages
Global
From €2979EUR$2,999USD£2,477GBP
- Report
- November 2023
- 160 Pages
Global
From €2979EUR$2,999USD£2,477GBP
- Report
- October 2023
- 158 Pages
Europe
From €2781EUR$2,799USD£2,312GBP
- Report
- October 2023
- 140 Pages
Global
From €2979EUR$2,999USD£2,477GBP
- Report
- October 2023
- 158 Pages
Latin America
From €3476EUR$3,499USD£2,890GBP
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more